333 related articles for article (PubMed ID: 25173780)
1. Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
van Waarde A; Rybczynska AA; Ramakrishnan NK; Ishiwata K; Elsinga PH; Dierckx RA
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2703-14. PubMed ID: 25173780
[TBL] [Abstract][Full Text] [Related]
2. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA
Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178
[TBL] [Abstract][Full Text] [Related]
3. Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.
Huang YS; Lu HL; Zhang LJ; Wu Z
Med Res Rev; 2014 May; 34(3):532-66. PubMed ID: 23922215
[TBL] [Abstract][Full Text] [Related]
4. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
5. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
6. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
7. Imaging sigma receptors: applications in drug development.
Collier TL; Waterhouse RN; Kassiou M
Curr Pharm Des; 2007; 13(1):51-72. PubMed ID: 17266588
[TBL] [Abstract][Full Text] [Related]
8. Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors.
Abate C; Selivanova SV; Müller A; Krämer SD; Schibli R; Marottoli R; Perrone R; Berardi F; Niso M; Ametamey SM
Eur J Med Chem; 2013 Nov; 69():920-30. PubMed ID: 24161678
[TBL] [Abstract][Full Text] [Related]
9. Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies.
Zeng C; McDonald ES; Mach RH
Handb Exp Pharmacol; 2017; 244():309-330. PubMed ID: 28176045
[TBL] [Abstract][Full Text] [Related]
10. Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection.
Bhuiyan MS; Fukunaga K
Expert Opin Ther Targets; 2011 Feb; 15(2):145-55. PubMed ID: 21204730
[TBL] [Abstract][Full Text] [Related]
11. Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (
Toussaint M; Deuther-Conrad W; Kranz M; Fischer S; Ludwig FA; Juratli TA; Patt M; Wünsch B; Schackert G; Sabri O; Brust P
Molecules; 2020 May; 25(9):. PubMed ID: 32384802
[TBL] [Abstract][Full Text] [Related]
12. Distinctive in vivo kinetics of the new σ1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.
Brust P; Deuther-Conrad W; Becker G; Patt M; Donat CK; Stittsworth S; Fischer S; Hiller A; Wenzel B; Dukic-Stefanovic S; Hesse S; Steinbach J; Wünsch B; Lever SZ; Sabri O
J Nucl Med; 2014 Oct; 55(10):1730-6. PubMed ID: 25071097
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS.
Waterhouse RN; Chang RC; Atuehene N; Collier TL
Synapse; 2007 Jul; 61(7):540-6. PubMed ID: 17447254
[TBL] [Abstract][Full Text] [Related]
14. Sigma1 Pharmacology in the Context of Cancer.
Kim FJ; Maher CM
Handb Exp Pharmacol; 2017; 244():237-308. PubMed ID: 28744586
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET.
Kawamura K; Kubota K; Kobayashi T; Elsinga PH; Ono M; Maeda M; Ishiwata K
Ann Nucl Med; 2005 Dec; 19(8):701-9. PubMed ID: 16444997
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.
Tu Z; Xu J; Jones LA; Li S; Dumstorff C; Vangveravong S; Chen DL; Wheeler KT; Welch MJ; Mach RH
J Med Chem; 2007 Jul; 50(14):3194-204. PubMed ID: 17579383
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent.
Moussa IA; Banister SD; Giboureau N; Meikle SR; Kassiou M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6820-3. PubMed ID: 21962578
[TBL] [Abstract][Full Text] [Related]
19. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).
Banister SD; Manoli M; Kassiou M
J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer.
Tu Z; Xu J; Jones LA; Li S; Zeng D; Kung MP; Kung HF; Mach RH
Appl Radiat Isot; 2010 Dec; 68(12):2268-73. PubMed ID: 20594864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
